semaglutide + cagrilintide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit What it is: a verified results Capsules:60

semaglutide + cagrilintide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit What it is: a verified results Capsules:60

What it is: a lab-made peptide (“body protection compound”), What research shows so far:, • Animal + limited human studies → enhanced wound, tendon, ligament healing, • May support angiogenesis (new ...

It was also shown that the knockdown of α-synuclein caused a decrease in surface expression of hDAT (Fountaine et al., 2008)

verified results

Capsules:60

“Serum IGF-1 levels increased by 40%” is a surrogate endpoint